Manu Jain
Researcher Next ID · RN-020182
Researcher · Medicine
Evanston, Philippines
- Works count
- 212
- Citation count
- 12,513
- H-index
- 45
- i10-index
- 85
Research interests
Publications
An integrated cell atlas of the lung in health and disease
Nature Medicine · 2023 · https://doi.org/10.1038/s41591-023-02327-2
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
Journal of Cystic Fibrosis · 2023 · 10.1016/j.jcf.2023.04.008
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32597-8
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages
European Respiratory Journal · 2019 · 10.1183/13993003.00646-2019
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine · 2018 · https://doi.org/10.1164/rccm.201712-2410oc
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
The Journal of Experimental Medicine · 2017 · https://doi.org/10.1084/jem.20162152
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Infection Control and Hospital Epidemiology · 2014 · 10.1086/676882
Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling
Journal of Biological Chemistry · 2012 · 10.1074/jbc.m112.431973
Nuclear β-Catenin Is Increased in Systemic Sclerosis Pulmonary Fibrosis and Promotes Lung Fibroblast Migration and Proliferation
American Journal of Respiratory Cell and Molecular Biology · 2011 · 10.1165/rcmb.2010-0113oc
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Thorax · 2011 · 10.1136/thoraxjnl-2011-200393
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Clinical Microbiology Reviews · 2011 · 10.1128/cmr.00036-10
PPARγ Downregulation by TGFß in Fibroblast and Impaired Expression and Function in Systemic Sclerosis: A Novel Mechanism for Progressive Fibrogenesis
PLoS ONE · 2010 · 10.1371/journal.pone.0013778
Beyond Mortality: Future Clinical Research in Acute Lung Injury
American Journal of Respiratory and Critical Care Medicine · 2010 · https://doi.org/10.1164/rccm.201001-0024ws
Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic Fibrosis
Journal of Clinical Microbiology · 2004 · 10.1128/jcm.42.11.5229-5237.2004
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
Microbiology · 2001 · 10.1099/00221287-147-10-2659
Current projects
No projects listed.